StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) operating KPIs

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)

Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%

Cvs Health aFS Debt Securities Maturing Within 1 Year (Fair Value) ($M)

Quarterly figures from Cvs Health's filings and investor materials

QuarterlyAnnual
Latest, Q2 2026
1,168
Period ended Jun 30, 2026
Change on a year earlier
+21.3%
963 in Q2 2025
History
30 quarters
Since Q4 2018
Sources
2
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAFS Debt Securities Maturing Within 1 Year (Fair Value) ($M)Year on yearSource
Q2 2026Jun 30, 20261,168+21.3%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q1 2026Mar 31, 2026852-28.3%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q4 2025Dec 31, 2025817+7.4%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q3 2025Sep 30, 2025838+2.7%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q2 2025Jun 30, 2025963-28.6%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q1 2025Mar 31, 20251,189-4.5%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q4 2024Dec 31, 2024761-38.1%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q3 2024Sep 30, 2024816-34.9%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q2 2024Jun 30, 20241,349+4.7%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q1 2024Mar 31, 20241,245-10.8%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q4 2023Dec 31, 20231,230-5.7%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q3 2023Sep 30, 20231,254-2.6%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q2 2023Jun 30, 20231,288+5.5%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q1 2023Mar 31, 20231,395+13.0%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q4 2022Dec 31, 20221,305+7.1%CVS SEC 10-K (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗
Q3 2022Sep 30, 20221,288+20.3%CVS SEC 10-Q (XBRL us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue) ↗

Cite this data

StockData. (2026). Cvs Health AFS Debt Securities Maturing Within 1 Year (Fair Value) ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/inv_afs_mat_within_1y

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.